Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches

Medicinal Research Reviews

Volumn 19, Issue 1, 1999, Pages 3-23

  Costantino, Luca ^a   Rastelli, Giulio ^a   Vianello, Paola ^b   Cignarella, Giorgio ^b   Barlocco, Daniela ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Istituto Chimico Farmaceutico   (Italy)

Author keywords

Advanced glycation end products (AGEs); Aldose reductase inhibitors (ARIs); Diabetes complications; Oxidative stress

Indexed keywords

1 [(3 BROMO 2 BENZO[B]FURANYL)SULFONYL]HYDANTOIN; 2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; 2 METHYLSORBINIL; 3 [(4,5,7 TRIFLUOROBENZOTHIAZOL 2 YL)METHYL] 5 METHYLPHENYLACETIC ACID; 3,4 DIHYDRO 2,8 DIISOPROPYL 3 THIOXO 2H 1,4 BENZOXAZINE 4 ACETIC ACID; ALDOSE REDUCTASE INHIBITOR; ALT 462; ALT 486; EPALRESTAT; ESSENTIAL FATTY ACID; FIDARESTAT; MINALRESTAT; NEUROTROPHIC FACTOR; PONALRESTAT; RISARESTAT; SCAVENGER; SG 210; SORBINIL; TOLRESTAT; UNCLASSIFIED DRUG; VASOACTIVE AGENT; WP 921; ZENARESTAT; ZOPOLRESTAT;

CATARACT; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; PROPHYLAXIS; REVIEW;

ALDEHYDE REDUCTASE; CATARACT; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; ENZYME INHIBITORS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032959371     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7     Document Type: Review

References (153)

1. Ammon HPT, Häring HU, Kellerer M, Laube H, Mosthaf L, Verspohl EJ, Wahl MA. In: Testa B, Meyer UA, editors. Advances in drug research 27. London: Academic; 1996.
2. Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 1997;20:1183.
3. Dvornik D. Croatica Chemica Acta 1996;69:613.
4. Newfield RS, Polak M, Marchase R, Czernichow P. Diabetologia 1997;40:B62.
5. Caprio S, Wong S, Alberti KGMM, King G. Diabetologia 1997;40:B78.
6. The diabetes control and complications trial research group. N Engl J Med 1993;329:977.
7. The diabetes control and complications trial research group. Arch Ophtalmol 1995;113:36.
8. The diabetes control and complications trial research group. Ann Intern Med 1995;122:561.
9. The diabetes control and complications trial research group. Kidney Int 1995;47:1703.
10. Porte Jr D, Schwartz MW. Science 1996;272:699.
11. Grimshaw CE. Biochem 1992;31:10139.
12. Kador PF. Med Res Rev 1988;8:325.
13. Tomlinson DR, Stevens EJ, Diemel L. Trends Pharm Sci 1994;15:293.
14. Masson EA, Boulton AJM. Drugs 1990;39:190.
15. Pfeifer MA, Schumer MP, Gelber DA. Diabetes 1997;46(Suppl2):S82.
16. Mealy N, Castañer I. Drugs Fut 1996;21:261.
17. Wyeth-Ayerst Company Communication. 1996.
18. Ward WHJ, Cook PN, Mirrlees DJ, Brittain DR, Preston J, Carey F, Tuffin DP, Howe R. Biochem Pharmacol 1991;42:2115.
19. Eggler JF, Larson ER, Lipinski CA, Mylari BL, Urban FJ. Adv in Med Chem 2. Jai Press; 1993. p 197.
20. Wrobel J, Millen J, Sredy J, Dietrich A, Kelly JM, Gorham BJ, Sestany K. J. Med Chem 1989;32: 2493.
21. Sarges R, Schnur RC, Belletire JL, Peterson MJ. J Med Chem 1988;31:230.
22. Sarges R. Aldose reductase inhibitors. In: Mutschler E. Winterfeldt E, editors. Trends in med chem. Weinheim: VCH; 1987.
23. Yamazishi M, Yamada Y, Ozaki K, Asao M, Shimizu R, Suzuki M, Matsumoto M, Matsuoka Y, Matsumoto K. J Med Chem 1992;35:2085.
24. Malamas MS, Hohman TC. Drugs Fut 1994;19:442.
25. Malamas MS, Hohman TC, Millen J. J Med Chem 1994;37:2043.
26. Kato K, Murakami N, Hasegawa Y, Nakayama K, Ohta M, Mizota M, Yamaguchi K, Ishiguro I, Miwa I, Okuda J. Diabetes 1991;40(Suppl 1):A346.
27. Wrobel J, Dietrich A, Woolson SA, Millen J, McCaleb M, Harrison MC, Hohman TC, Sredy J, Sullivan D. J Med Chem 1992;35:4613.
28. Costantino L, Rastelli G, Cignarella G, Vianello P, Barlocco D. Exp Opin Ther Patents 1997;7:843.
29. Lipinski CA, Aldinger CE, Beyer TA, Bordner J, Burdi DF, Bussolotti DL, Inskeep PB, Siegel TW. J Med Chem 1992;35:2169.
30. Mylari BL, Zembrowski WJ, Beyer TA, Aldinger CE, Siegel TW. J Med Chem 1992;35:2155.
31. Wilson DK, Tarle I, Petrash JM, Quiocho FA. Proc Natl Acad Sci USA 1993;90:9847.
32. Ishii A, Kotani T, Nagaki Y, Shibayama Y, Toyomaki Y, Okukado N, Ienaga K, Okamoto K. J Med Chem 1996;39:1924.
33. Kotani T, Ishii A, Nagaki Y, Toyomaki Y, Yago H, Suehiro S, Okukado N, Okamoto K. Chem Pharm Bull 1997;45:297.
34. Kotani T, Nagaki Y, Ishii A, Konishi Y, Yago H, Suheiro S, Okukado N, Okamoto K. J Med Chem 1997;40:684.
35. Bohren KM, Bullock B, Wermuth B, Gabbay KH. J Biol Chem 1989;264:9547.
36. Feather MS, Flynn TG, Munro KA, Kubieski TJ, Walton DJ. Biochim Biophys Acta 1995;1244:10.
37. Rattliff DM, Jagt DJV, Eaton RP, Jagt DLV. J Clin Endocrinol Metab 1996;81:488.
38. Aotsuka T, Abe N, Fukushima K, Ashizawa N, Yoshida M. Bioorg Med Chem Lett 1997;7:1677.
39. Ashizawa N, Yoshida M, Sugiyama Y, Akaike N, Ohbayashi S, Aotsuka T, Abe N, Fukushima K, Matsuura A. Jpn J Pharmacol 1997;73:133.
40. Sarges R. Adv Drug Res 1989;18:139.
41. Humber LG. Prog Med Chem 1987;24:299.
42. Janecek S, Bateman A. Biologia Bratislava 1996;51:613.
43. Rondeau JM, Tete-Favier F, Podjarni A. Nature 1992;355:469.
44. Wilson DK, Bohren KM, Gabbay KH, Quiocho FA. Science 1992;257:81.
45. Bohrani DW, Harter TM, Petrash JM. J Biol Chem 1992;267:24841.
46. Tete-Favier F, Barth P, Mitchler A, Podjarny AD, Rondeau J-M, Urzhumtsev A, Biellmann J-F, Moras D. Eur J Med Chem 1995;30S:589s.
47. Grimshaw CE, Shabbaz M, Putney CG. Biochem 1990;29:9947.
48. Kubeseski TJ, Hindman DJ, Morjana NA, Flynn TG. J Biol Chem 1992:267:6510.
49. Bohren KM, Grimshaw CE, Lai CJ, Harrison DH, Ringe D, Petsko GA, Gabbay KH. Biochem 1994;33:2021.
50. Grimshaw CE, Bohren KM, Lai CJ, Gabbay KH. Biochem 1995;34:14374.
51. Harrison DH, Bohren KM, Ringe D, Petsko GA, Gabbay KH. Biochem 1994;33:2011.
52. Urzhumtsev A, Tete-Favier F, Mitscler A, Barbanton J, Barth P, Urzhumgtseva L, Biellmann JF, Podjarny AD, Moras D. Structure 1997;5:601.
53. Harrison DHT, Bohren KM, Petsko GA, Ringe D, Gabbay KH. Biochem 1997;36:16134.
54. De Winter HL, von Itzstein M. Biochem 1995;34:8299.
55. Lee YS, Hodoscek M, Brooks BR, Kador PF. Biophys Chem 1998;70:203.
56. Costantino L, Rastelli G, Vescovini K, Cignarella G, Vianello P, Del Corso A, Cappiello M, Mura U, Barlocco D. J Med Chem 1996;39:4396.
57. Rastelli G, Vianello P, Barlocco D, Costantino L, Del Corso A, Mura U. Bioorg Med Chem Lett 1997;7:1897.
58. Rastelli G, Costantino L. Bioorg Med Chem Lett 1998;8:641.
59. Rastelli G, Costantino L, Vianello P, Barlocco D. Tetrahedron, 1998;54:9415.
60. Sima AAF, Thomas PK, Ishii D, Vinik A. Diabetologia 1997;40:B74.
61. Shipanova IN, Glomb MA, Nagaraj RH. Arch Biochem Biophys 1997;344:29.
62. Njoroge FG, Monnier VM. Prog Clin Biol Res 1989;304:85.
63. Ledl F, Schleicher E. Angew Chem 1990;29:565.
64. Eble AS, Thorpe SR, Baynes JW. J Biol Chem 1983;258:9406.
65. Brownlee M. In: Rifkin H. Porte D, editors. Diabetes mellitus: theory and practice. New York: Eisevier; 1990. p 279-291.
66. Baynes JW, Thorpre SR, Murtiashaw MH. In: Wold F, Moldave K, editors. Methods in enzymology: post-translational modifications 106. New York: Academic; 1984. p 88-98.
67. Kato H, Hayase F, Shin DB, Oimomi M, Baba S. In: Baynes JW, Monnier VM, editors. Proceedings of the NIH conference on the Maillard reaction in aging, diabetes and nutrition. New York: Liss; 1989. p 69-84.
68. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. J Biol Chem 1991;266:11654.
69. Horiuchi S, Araki N, Morino Y. J Biol Chem 1991;266:7329.
70. Knecht KG, Feather MS, Baynes JW. Arch Biochem Biophys 1992;294:30.
71. Hoshi A, Takahashi M, Fujii J, Myint T, Kaneto H, Suzuki K, Yamasaki Y, Kamada T, Taniguchi N. Biochem J 1996;318:119.
72. Friedlander MA, Witko-Sarsat V, Nguyen AT, Ching Wu Y, Labrunie M, Verger C, Jungers P, Descamps-Latscha B. Clinical Nephrology 1996;45:379.
73. Khalifah RG, Todd P, Booth A, Yang SX, Mott JD, Hudson BG. Biochem 1996;35:4645.
74. Brownlee M. Diabetes 1994;43:836.
75. Monnier VM, Glomb M, Elgawish A, Sell DR. Diabetes 1996;45(Suppl3):S67.
76. Taniguchi N, Kaneto H, Asahi M, Takahashi M, Wenyi C, Higashiyama S, Fujii J, Suzuki K, Kayanoki Y. Diabetes 1996;45(Suppl3):S81.
77. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M. Vlassara H. J Exp Med 1991;174:515.
78. Patel J, Kligman D. J Biol Chem 1997;262:16686.
79. Sakai K, Hirai M, Minoshima S, Kudoh J, Fukujama R, Shimizu N. Genomics 1989;5:309.
80. Vlassara H, Li YM, Imani F, Vojciechowicz D, Yang Z, Liu FT, Cerami A. Mol Med 1995;1:634.
81. Vlassara H, Bucala R. Diabetes 1996;45(Suppl3):S65.
82. Vlassara H. Diabetes 1997;46(Suppl2):S19.
83. Horiuchi S, Higashi T, Ikeda K, Saishoji T, Jinnouchi Y, Sano H, Shibayama R, Sakamoto T, Araki N. Diabetes 1996;45(Suppl3):S73.
84. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Science 1986;232:1629.
85. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL. Diabetes 1992;41:552.
86. Pimagedine, Drugs Fut 1995;20:84.
87. Pimagedine, Drugs Fut 1997;22:917.
88. Kochakian M, Manjuh BN, Egan JJ. Diabetes 1996;45:1694.
89. Miwa I, Tsugava T, Koyasu K, Terada Y. Pharmacology 1996;52:314.
90. Satoh F et al. Kissei Pharm Co Ltd, WO 9636591.
91. Satoh F et al. Kissei Pharm Co Ltd, JP 97059233.
92. Lankin ME et al. Alteon Inc, WO 9640622.
93. Matsui T et al. Ono Pharm Co Ltd, JP 97059258.
94. Nakamura S et al. Diabetes 1997;46:895.
95. Nakamura S et al. Diabetes 1997;46(Suppl1):Abst 0181.
96. Nakamura S et al. J Amer Soc Nephrol 1996;7:1875.
97. 255510. Annual Drug Data Report 1998;20:52.
98. 256202. Annual Drug Data Report 1998;20:52.
99. Cohen MP. Advances in the management of diabetic complications and novel therapeutic development. London: The Royal Society; 1998.
100. Huby R, Harding JJ. Exp Eye Res 1988;47:53.
101. Bruno MR, Sensi M, Cioccia GP, Valente L, Negri M, Ghirlanda M, Pozzilli P. Diabetes Res 1988;9:11.
102. Sensi M, Pricci F, De Rossi MG, Morano S, Di Mario U. Clin Chem 1989;35:384.
103. Raza K, Harding JJ. Exp Eye Res 1991;52:205.
104. Vinson JA, Howard III TB. Nutr Biochem 1996;7:659.
105. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Diabetes Care 1991;14:68.
106. Menzell EJ, Reihsner R. Diabetologia 1991;34:12.
107. Le Guen CA, Bain S, Barnett AH, Lunec J. Agents Action 1992;36:264.
108. van Boekel MAM, van den Bergh PJPC, Hoenders HJ. Biochim Biophys Acta 1992;120:201.
109. Kawabata T, Packer L. Biochem Biophys Res Commun 1994;203:99.
110. Baynes JW. Diabetes 1991;40:405.
111. Drickamer K. Nature 1996;382:211.
112. Vassan S, Zhang X, Zang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P. Nature 1996;382:275.
113. Giugliano G, Coppola L. Giornale Italiano di Diabetologia 1997;17:111.
114. Stadtman ER. Science 1992;257:1220.
115. Kashiwagi A, Asahina T, Nishio Y, Ikebuchi M, Tanaka Y, Kikkawa R, Shigeta Y. Diabetes 1996;45 (Suppl3):S84.
116. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Biochem Med 1979;21:104.
117. Jain SK. J Biol Chem 1989;264:21340.
118. Morel DM, Chisolm GM. J Lipid Res 1989;30:1827.
119. Tesfamarian B, Cohen RA. Am J Physiol 1992;263:H321.
120. Wolff SP, Dean RT. Biochem J 1987;245:243.
121. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Proc Natl Acad Sci USA 1993;90:6434.
122. Lyons TJ, Jenkins AJ. Diabetes Rev 1997;5:365.
123. Nickander KK, Schmelzer JD, Rohwer DA, Low PA. J Neurol Sci 1994;126:6.
124. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Trischler H, Low PA. Diabetes Care 1995;18:1160.
125. Low PA, Nickander KK, Tritschler HJ. Diabetes 1997;46(Suppl2):S38.
126. Kalyanaraman B, Darley-Usmar VM. Wood J, Joseph J, Partasarathy S. J Biol Chem 1992;267:6789.
127. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. Diabetologia 1994;37:449.
128. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR. Diabetologia 1995;38:129.
129. Bravenboer B, Kappelle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH. Diabetologia 1992;35:813.
130. Cameron NE, Cotter MA, Maxfield EK. Diabetologia 1993;36:299.
131. Cotter MA, Cameron NE. Naunyn Schmiedebergs Arch Pharmacol 1995;351:630.
132. Cameron NE, Cotter MA. J Clin Invest 1995;96:1159.
133. ONO-1505. Annu Drug Data Rep 1993;15:59.
134. Civelli M, Giossi M, Caruso P, Razzetti R, Bergamaschi M, Bongrani S, Gasco A. Brit J Pharmacol 1996;118:923.
135. KDI-792. Drugs Fut 1996;21:1224.
136. Sone H, Okuda Y, Tsurushima Y, Asano M, Suzuki S, Kawakami Y, Yamashita K. Prostaglandins 1996;53:395.
137. 254118. Annu Drug Data Report 1997;3.
138. Zopolrestat. Drugs Fut 1997;2:97.
139. Bilous RW, Fioretto P, Czernicochow P, Drummond K. Diabetologia 1997;40:B68.
140. Polak M, Newfield RS, Fioretto P, Czernichow P, Marchase R. Diabetologia 1997;40:B65.
141. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL. Science 1996;272:728.
142. 242595. Annual Drug Data Report 1997;144.
143. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald III JH, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winnerovski LL, Faul MM. J Med Chem 1996;39:2664.
144. Markussen J, Schiff HE. Int J Pept Protein Res 1973;5:69.
145. Snell CR, Smyth DG. J Biol Chem 1975;250:6291.
146. Kitabchi AE. Metabolism 1977;26:547.
147. Steiner DF. Diabetes 1978;27(Suppl1):145.
148. Ido Y, Vindigni A, Chang K. Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR. Science 1997;277:563.
149. Johansson BL, Sjberg S, Wahren J. Diabetologia 1992;35:121.
150. Johansson BL, Kernell A, Sjberg S, Wahren J. J Clin Endocrinol Metab 1993;77:976.
151. Steiner DF, Rubenstein AH. Science 1997;277:531.
152. Mann JI. Diabetes 1997;46(Suppl2):S125.
153. Stahl, Sies H. Diabetes 1997;46(Suppl2):S14.